VMP 42137611000001107

Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants

Name Topiramate 25mg tablets
BNF code 040801050AAADAD
Virtual Therapeutic Moiety Topiramate
Date identifier became valid 4 Aug 2023
Previous product identifier 323029005
Basis of preferred name rINN - Recommended International Non-proprietary
Prescribing status Valid as a prescribable product
Sugar free
Gluten free
Preservative free
CFC free
Dose form Discrete
Unit dose form size 1.000
Unit dose form units tablet
Unit dose unit of measure tablet
Virtual Product Ingredient
Ingredient Topiramate
Basis of pharmaceutical strength Based on Ingredient Substance
Strength value numerator 25.000
Strength value numerator unit mg
Ontology Drug Form & Route
Form & Route tablet.oral
Dose Form
Formulation Oral tablet
Drug Route
Route Oral
Controlled Drug Prescribing Information
Controlled Drug category No Controlled Drug Status
Actual Medicinal Products
Topamax 25mg tablets (CST Pharma Ltd)
Topamax 25mg tablets (Janssen-Cilag Ltd)
Topamax 25mg tablets (Sigma Pharmaceuticals Plc)
Topiramate 25mg tablets (A A H Pharmaceuticals Ltd)
Topiramate 25mg tablets (Accord-UK Ltd)
Topiramate 25mg tablets (Alissa Healthcare Research Ltd)
Topiramate 25mg tablets (Alliance Healthcare (Distribution) Ltd)
Topiramate 25mg tablets (Crescent Pharma Ltd)
Topiramate 25mg tablets (Ennogen Healthcare International Ltd)
Topiramate 25mg tablets (Medihealth (Northern) Ltd)
Topiramate 25mg tablets (Milpharm Ltd)
Topiramate 25mg tablets (Novumgen Ltd)
Topiramate 25mg tablets (Phoenix Healthcare Distribution Ltd)
Topiramate 25mg tablets (Torrent Pharma (UK) Ltd)
Virtual Medicinal Product Packs
Topiramate 25mg tablets 28 tablet
Topiramate 25mg tablets 60 tablet

dm+d data retrieved from TRUD: release NHSBSA_11.2.0_20241118000001, imported on 19th November 2024 at 03:53:26.

Feedback